retatrutide thirsty Starting Retatrutide? Avoid These 12 Costly Mistakes Don’t risk your health with

Bagur MJ, Murcia MA, Jimnez-Monreal AM, et al

Very convincing data that combined therapy with SGLT-2i and GLP-1 RA is much more efficacious in decreasing CV, renal and HF outcomes than monotherapies This is somehing that all of us expects but we have no strong prospective randomized data Also, the safety of combination appears to be fine Nice paper on a very important topic

GSKs share price dipped initially by 0.6% before rising 7% to close at a 26 year high of 20.80

This one is a softer, optional addition rather than a core GLP-1 supplement, and we want to be clear about that framing

Adverse events were reported infrequently and were minor

Nutrition changes could be a culprit